This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Margaret A. Winker, MD
Senior Editor, JAMA Chicago, Ill

Margo Denke, MD
University of Texas Southwestern Medical Center Dallas

JAMA. 1996;275(2):110-111.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We appreciate the comments of Dr Krumholz and colleagues and agree that the methods used at each independent site of EPESE were not identical. We also appreciate that the measures used in the study were relatively standard: measurements of lipid levels presumably were comparable across sites, and the measurements of outcomes, while not standardized for secondary analyses, were consistent in terms of mortality, the primary end point of the combined site analysis.¹ The verification of myocardial infarction and unstable angina with chart review at the New Haven site² would not explain the differences in mortality rates between New Haven and the other sites.

We also appreciate that the New Haven cohort had "unique sample characteristics and health status characteristics,"³ with the "lowest CHD mortality... but the highest death rate from non-CHD cardiovascular disease."¹ While this may have been a reason to publish the results . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?